Same stool, different verdicts: what home gut microbiome tests can tell you

Key takeaways

• When federal scientists sent identical stool material to seven home-testing companies, the differences between companies were about as large as the differences between people.
• A 2025 consensus of 69 experts from 18 countries found too little evidence to recommend routine microbiome testing and said “healthy” reference ranges aren’t supported yet.
• The same experts said test providers shouldn’t give treatment advice, yet some companies recommend probiotics and supplements they sell themselves.
• The FDA generally doesn’t review wellness tests, and a 2024 rule that would have widened its oversight of lab-made tests was struck down by a federal court in March 2025.
• Stool tests a clinician orders for blood, infection or C. diff do a different job; bleeding, black stools, weight loss or frequent diarrhea after antibiotics call for a clinician, not a kit.

Scientists at the National Institute of Standards and Technology (NIST), the federal agency that sets measurement standards, ran a simple check on a booming industry. They bought 21 home gut microbiome kits, three from each of seven companies¹.

Every kit got the same thing: a portion of reference stool material that NIST had pooled from one donor and blended so each portion matched¹². If the tests measured the gut reliably, the reports should have looked alike.

They didn’t. Across the companies’ reports and NIST’s own lab checks, 1,208 different microbial groups turned up, yet only three genera appeared in every sample¹. One company rated two of its three identical samples “healthy” and the third “unhealthy”¹².

The study, published in Communications Biology in February 2026, found that the gap between companies was about as big as the natural gap between different people¹³. Put plainly, the lab you pick can shape your results about as much as whose gut it is.

That matters if you care about gut health, as many natural-health readers do. Gut microbes are real and important. The question is whether a mail-in kit can tell you anything you can act on.

How a mail-in kit turns stool into a “gut score”

You collect a small sample at home and mail it in. The lab pulls DNA out of the sample, reads it with a sequencing machine and matches the pieces against databases of known microbes. Software then turns that list into charts, scores and advice.

There are two main ways to read the DNA. 16S sequencing, also called amplicon sequencing, reads one marker gene that bacteria carry. It costs less and usually identifies bacteria to the genus, a group of related species⁴.

Shotgun metagenomic sequencing reads DNA from across the whole sample. It can reach the species or even strain level and estimate what the microbes might be able to do⁴. Experts consider both methods acceptable for describing a gut community⁴. In the NIST study, three companies used marker-gene sequencing and four used shotgun sequencing¹.

The method is only one step. Labs also differ in how they break open cells, how deeply they sequence, which databases they use and the cutoffs they set for reporting a microbe¹³.

Those choices add up. In the NIST study, the amount of sequencing ranged from under 20,000 reads to more than 10 million, and companies reported anywhere from 34 to 906 genera¹. Results took two to eight weeks to arrive¹.

One sample, seven companies, little agreement

Six companies returned all three reports. The seventh returned two and said one sample failed, and a replacement sample also failed its quality check¹.

Clostridium, a group of bacteria that includes the infection-causing C. difficile, was among the least consistent. A large research effort called the American Gut Project found an average of just over 2.5% Clostridium in people’s guts².

Against that benchmark, the reports scattered. One company put Clostridium at roughly fivefold the American Gut average. Three others came back with no Clostridium at all in some of their reports².

On the species C. difficile itself, the seven companies split three to four: three said it was present, four said it wasn’t¹.

The scientists also built a consensus picture of 18 common genera and compared it with stool from eight different donors that NIST tested itself. For 17 of the 18, the differences between testing methods were at least comparable to the differences between donors¹.

The company that called the same material both healthy and unhealthy offers the clearest warning. Its third report scored below average in seven of ten “functional” categories, compared with one category in each of the other two reports¹.

The authors said analytical validity, meaning whether a test measures what it claims to measure reliably, has to come before anyone reads health meaning into results³. Many companies, they noted, share little about their methods³.

Scientists still can’t say what a healthy gut looks like for you

In 2025, 69 experts from 18 countries published a consensus statement on microbiome testing in The Lancet Gastroenterology & Hepatology⁴. They voted in structured rounds and counted a statement as agreed only if at least 80% supported it⁴.

Their verdict was cautious. There isn’t enough evidence to recommend routine microbiome testing, and providers should tell customers how thin the evidence is⁴. The panel also discouraged people from ordering tests on their own without a clinician’s recommendation⁴.

The experts went further on the report contents many customers see. Strict “healthy” ranges for how much of each microbe you should carry aren’t supported yet, they said. Dysbiosis indices, single scores claiming your gut is out of balance, lack enough evidence⁴.

Houston Methodist gastroenterologist Arvind Reddy made the same point in 2024: there is no benchmark yet for a normal gut microbiome¹³. Because even healthy guts differ so much from one person to the next, pinning down what counts as “out of balance” is hard¹³.

The NIST team added a regulatory fact. No U.S. regulator has approved a clinical microbiome diagnostic test¹.

When the test company also sells the fix

Here the incentives get tangled. The 2025 consensus panel agreed, at 98%, that testing providers should not give treatment advice after a test⁴. Changes to care, they said, should come from the clinician who referred you⁴.

Many consumer reports do the opposite. The NIST authors found most advice centered on eating better, but some companies urged customers to buy costly supplements, such as probiotics, sold by the same company, despite limited evidence¹. A gastroenterologist interviewed by MDedge in 2024 said that when a company sells probiotics alongside its test, some conflict of interest is almost certain¹⁴.

Probiotics deserve the same scrutiny as any other product. The National Center for Complementary and Integrative Health (NCCIH) says different probiotics can have different effects, so a result for one kind doesn’t necessarily apply to another¹⁰. Researchers still don’t know which species or strains help, at what doses, or for whom¹⁰.

Many probiotics are sold as dietary supplements, which don’t need FDA approval before they go on sale¹⁰. Some products have contained microbes that weren’t on the label¹⁰. Harmful effects are more likely in people who are very sick or have weakened immunity. In 2023, the FDA alerted health care providers that premature infants given probiotics risk severe, even fatal, infections¹⁰.

You’d ask a drug company who benefits from your belief in its test. Ask a gut-testing company the same thing. When the lab that scores your gut also sells the cure for a low score, treat the score as a sales tool until someone shows otherwise.

Who checks these kits? Less oversight than you’d expect

The FDA says it generally reviews home tests meant for moderate- or high-risk medical uses, not tests sold for general wellness⁶. The NIST authors placed most microbiome kits in a gray zone, somewhere between tightly overseen medical tests and lightly policed wellness products¹³.

A bigger change was briefly on the books. In May 2024, the FDA finalized a rule stating that tests made by laboratories count as medical devices⁵. A federal court in Texas vacated that rule on March 31, 2025, in American Clinical Laboratory Association v. FDA. The FDA removed the rule’s language on September 19, 2025⁵.

The 2025 expert panel wants testing labs to be accredited, registered and regulated, ideally by national authorities⁴. Ask about that before you buy, because the FDA doesn’t review most wellness kits⁶.

The industry’s best-known collapse shows what can go wrong. San Francisco-based uBiome started with Gut Explorer, a consumer kit first priced below $100. Its clinical version, SmartGut, was billed to insurers at around $2,970 a test, The Register reported⁹.

In 2021, the Securities and Exchange Commission charged uBiome’s co-founders with a $60 million fraud. The SEC alleged that the company’s insurance revenue depended on misleading doctors into ordering unnecessary tests⁷. A federal grand jury indicted the pair on securities and health care fraud conspiracy charges⁸.

These are allegations, and the founders had not been arrested when the charges were announced⁹. uBiome went bankrupt⁷.

The stool tests your doctor orders do a different job

Not every stool test is a microbiome test. Clinicians use stool tests to look for blood and for signs of infection or disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)¹². Targeted germ tests, such as PCR panels and lab cultures, answer a different question, and experts say they don’t count as microbiome testing⁴.

Take C. difficile, a bacterium that can cause severe diarrhea, often after antibiotics. The CDC tells clinicians to test patients with diarrhea who have had three or more stools in 24 hours, unless a laxative or stool softener explains it¹¹. Antibiotics, a past C. diff infection, age 65 or older and a recent hospital or nursing home stay all raise the risk¹¹.

That’s a clear question with a validated answer. A wellness kit can’t replace it, as the split NIST results on C. difficile show¹.

Signs that you need a clinician, not a kit

NIDDK says some symptoms may point to a problem other than irritable bowel syndrome, and doctors weigh them, along with family history, when deciding on more tests¹²:

• anemia
• bleeding from the rectum, or bloody or black, tarry stools
• weight loss
• a family history of celiac disease, colon cancer or inflammatory bowel disease

Add frequent loose stools during or after antibiotics, which can signal C. diff¹¹. Don’t stop a prescribed medicine or overhaul your diet before testing unless your clinician advises it⁴. Experts warn that home test results can lead people to delay a diagnosis or stop needed medicine¹⁴.

Respecting the gut means respecting its complexity

Natural-health traditions often treat the body as an ecosystem, not a machine with parts to swap. Microbiome science fits that view. The microbes in healthy guts differ widely from person to person¹³, and researchers can’t yet boil them down to a single grade⁴.

That humility is a strength, not a weakness. A kit that turns your gut into a score and a shopping cart claims more certainty than the science has. Your own observations, such as how foods sit with you, your energy and your regularity, are information too, and they cost nothing.

If you have ongoing symptoms, the most natural next step is a clinician who looks at the whole picture, not a report built from one scoop.

Ten questions to ask before you mail a sample

1. What do I want to know? If the question is “Why do I have bleeding, weight loss or ongoing diarrhea?”, see a clinician first¹¹¹².
2. Will a clinician help me read it? Experts discourage self-ordered tests and say only a clinician should change your care based on results⁴.
3. Does the company name its method? 16S and shotgun sequencing are both acceptable⁴. A company that won’t explain how it tests leaves you unable to compare¹³.
4. Does it publish repeat-testing data? Ask how often the same sample gets the same result. One company in the NIST study split two to one on identical material¹.
5. Is the lab accredited or overseen by a national authority? Experts say it should be⁴.
6. Does the report lean on a single score? A dysbiosis index, gut health score or Firmicutes-to-Bacteroidetes ratio isn’t backed by enough evidence⁴.
7. Does the company sell what it recommends? Probiotics, supplements or meal plans tied to your results signal a conflict of interest¹¹⁴.
8. What is the full cost? Add subscriptions, retests and add-on products. Insurance generally doesn’t cover these tests¹⁴.
9. Who keeps my sample and data? Find out how to delete both before you mail anything.
10. Will I act on the answer? Most advice in the NIST study centered on healthier eating¹. You can start that today without a test.

What the evidence supports, claim by claim

Claim	What research shows	Evidence level
“Whichever kit you pick, you’ll get the same picture of your gut.”	Seven companies returned widely different results on identical material12	Evidence says no
“Comparing you with a healthy range shows what’s wrong.”	Experts say strict healthy ranges aren’t supported yet413	Not enough evidence
“A gut health or dysbiosis score tracks your health.”	Too little evidence, and one company scored identical samples both ways14	Not enough evidence
“Probiotics matched to your results will fix an imbalance.”	Effects are strain-specific; experts say test providers shouldn’t give treatment advice410	Not enough evidence
“A microbiome test can diagnose IBS or other disease.”	No U.S.-approved clinical microbiome diagnostic; not enough evidence for routine use14	Not enough evidence
“Microbiome profiles may one day help manage some disorders.”	Experts see possible value but say evidence isn’t ready for practice4	Promising but early
“Clinician-ordered stool tests find infection and bleeding.”	Standard tools for C. diff and for checking blood and infection1112	Strong evidence

Questions readers ask

The bottom line

Home microbiome kits sell a map of your gut. The best current evidence says the map changes depending on which company draws it, no one has defined healthy terrain for an individual, and the suggested route often runs through the company’s own store.

If you’re curious and the cost doesn’t worry you, treat the report as a curiosity, not a care plan. If you have symptoms, start with a clinician and the validated stool tests they can order. Your gut deserves careful attention, which is exactly why it deserves better than a guess.

Related reading

• When the company reading your labs also sells the fix
• Why one flagged lab number is not a diagnosis
• Most health products aren’t scams, but many just haven’t been proven
• DNA kits read a sliver of your genes, and the data can be sold
• Health apps share more than you think, and you can lock yours down

Sources

1. Servetas SL, Gierz KS, Hoffmann D, Ravel J, Jackson SA. “Evaluating the analytical performance of direct-to-consumer gut microbiome testing services.” Communications Biology, 2026. nature.com
2. Springer Nature. “Health: Gut health home-testing kit outcomes vary between kits and manufacturers.” Press release, Nature Asia, 2026. natureasia.com
3. University of Maryland School of Medicine, Center for Advanced Microbiome Research and Innovation. “How reliable are direct-to-consumer microbiome tests?” CAMRI, 2026. camri.umaryland.edu
4. Porcari S, Mullish BH, Asnicar F, et al. “International consensus statement on microbiome testing in clinical practice.” The Lancet Gastroenterology & Hepatology, 2025. edepot.wur.nl
5. U.S. Food and Drug Administration. “Medical Devices; Laboratory Developed Tests; Implementation of Vacatur.” Federal Register, 2025. public-inspection.federalregister.gov
6. U.S. Food and Drug Administration. “Direct-to-Consumer Tests.” FDA, 2019. fda.gov
7. U.S. Securities and Exchange Commission. “SEC Charges Co-Founders of San Francisco Biotech Company with $60 Million Fraud.” Litigation Release No. 25056, SEC, 2021. sec.gov
8. U.S. Department of Health and Human Services, Office of Inspector General. “uBiome Co-Founders Charged With Federal Securities, Health Care Fraud Conspiracies.” HHS-OIG, 2021. oig.hhs.gov
9. The Register. “Founders of medical science upstart uBiome once likened to Theranos now indicted for, you guessed it, fraud.” The Register, 2021. theregister.com
10. National Center for Complementary and Integrative Health. “Probiotics: Usefulness and Safety.” NIH. nccih.nih.gov
11. Centers for Disease Control and Prevention. “C. diff: Facts for Clinicians.” CDC, 2026. cdc.gov
12. National Institute of Diabetes and Digestive and Kidney Diseases. “Diagnosis of Irritable Bowel Syndrome.” NIH. niddk.nih.gov
13. McCallum K. “Should You Do a Gut Microbiome Test?” Houston Methodist, 2024. houstonmethodist.org
14. Larkin M. “Are Direct-to-Consumer Microbiome Tests Clinically Useful?” MDedge, 2024. mdedge.com